Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Sun Pharma launches Chericof® 12 in India, a novel formulation that provides relief from cough for up to 12 hours

Posted On: 2021-09-28 14:35:29 (Time Zone: IST)


Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associate companies) today announced the launch of a novel formulation in cough management - Chericof® 12 (Dextromethorphan Hydrobromide 30 mg and Chlorpheniramine Maleate 4 mg) in India. Chericof® 12, the first prescription cough syrup in India which gives relief for up to 12 hours, is manufactured using Polistirex technology for sustained release of the drug. Chericof® 12 is approved for patients of age group six years and above.

All cough syrups generally give relief for 6-8 hours, and hence a patient has to take it three to four times a day. Frequent dosing often leads to patient inconvenience and non-adherence to follow the regimen, which may compromise the efficacy of the medication and disturb the daily lifestyle. As per a study, a twice-a-day dosing regimen was associated with significantly better compliance in 70% of patients than threetimes a day (52%) and four-times a day (42%) dosing regimen, respectively1. The Polistirex technology used in Chericof® 12 provides sustained release of the medicine in the body, thus offering up to 12 hour relief to patients with twice-daily dosage.

Kirti Ganorkar, CEO - India Business, Sun Pharma said "At Sun Pharma, we always endeavour to introduce differentiated medicines that enhance convenience or solve patients' problems, thus helping them to cope better with their ailments. The Polistirex technology used in Chericof® 12 helps in improving patient compliance and avoids the need for frequent dosing."

Polistirex Technology involves the complexation of two drugs, Dextromethorphan Hydrobromide and Chlorpheniramine maleate with resins. The resin granules of both drugs are added in suspension to form Chericof® 12. Complexation of drugs with polistirex not only provides sustained release but also masks the bitter taste making it more palatable.

Chericof® 12 is a prescription product and should only be taken on the doctor's advice.

Shares of Sun Pharmaceutical Industries Ltd. was last trading in BSE at Rs. 762.95 as compared to the previous close of Rs. 769.7. The total number of shares traded during the day was 62229 in over 2328 trades.

The stock hit an intraday high of Rs. 774.15 and intraday low of 760.1. The net turnover during the day was Rs. 47649887.


Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Canara Bank reports consolidated PAT of Rs. 1100.59 crore in Q2FY22

Veer Global Infraconstruction Limited board approves draft letter of offer for rights issue

Allcargo Logistics clarifies on IPL team bid

Goa Carbon Ltd resumes operations at Bilaspur Unit from Oct 25, 2021

W S Industries Ltd to consider sale of 13.71 acres of land

Manappuram Finance Ltd rating upgraded to 'BB-/B', Outlook Stable

Rattanindia backed Revolt opens EV dealership in Jaipur

SecureKloud Technologies Limited allots 2,84,000 shares on conversion of warrants

IEX to commence trade in Energy Saving Certificates under PAT Cycle- II on 26 October 2021

Glenmark becomes the first company to launch Remogliflozin + Vildagliptin + Metformin fixed dose combination

Godrej Properties in partnership with Dasra Launches report

EOS Data Analytics Partners up with Cambridge Technology in the agriculture and forestry sectors

Balu Forge Industries Ltd Board to consider Interim Dividend for FY22

Karda Constructions Ltd announces Q2FY22 results

ICRA Ltd reports consolidated PAT of Rs. 24.05 crore in Q2FY22

IndiGo partners Kotak Mahindra Bank for Ka-ching co-branded credit card

Apollo Hospitals announces free COVID vaccinations for children with Co-Morbidities

Bharat Petroleum to strengthen rural market connect with launch of new campaign by MAK Lubricants

ANG Lifesciences India Ltd board declares interim dividend of Rs. 1

Home First Finance Company India Limited - Highlights for Q2FY22

Advitiya Trade India Ltd to consider migration to main board of BSE

Quick Heal Technologies Ltd Q2FY22 consolidated PAT at Rs. 34.62 crore

ANG Life Sciences India Ltd H1FY22 consolidated PAT zooms to Rs. 33.77 crore

Jagran Prakashan Ltd posts consolidated net profit of Rs. 61.83 crore in Q2FY22

Choksi Imaging Ltd posts Rs. 46.46 lakhs net profit in Q2FY22

CEAT Ltd consolidated Q2FY22 net profit climbs QoQ to Rs. 41.98 crore

Sheetal Diamonds Ltd Q2FY22 loss at Rs. 40.44 lakhs

Orbit Exports Ltd Q2FY22 consolidated net profit higher at Rs. 4.54 crore

Indus Towers Ltd reports Rs. 1558.5 crore consolidated profit in Q2FY22

Sagar Productions Ltd posts Rs. 11.26 lakhs PAT in Q2 FY2021-22

Orient Cement Ltd reports Rs. 56.88 crore profit in Q2 FY22

Shreenath Investment Company Ltd Q2FY22 PAT slides to Rs. 5.61 lakhs

Home First Finance Company India Ltd posts Rs. 44.86 crore PAT in Q2 FY2021-22

Hardcastle and Waud Mfg Co. Ltd. Q2FY22 profit jumps to Rs. 69.41 lakhs

LKP Securities Ltd Q2FY22 consolidated net profit at Rs. 3.80 crore

Mangalam Organics Limited to double Camphor production capacity to 10,000 MTPA

Dwarikesh Sugar Industries Ltd - Q2FY22 Highlights

Kansai Nerolac Paints Ltd board declares interim dividend of Rs. 1.25

Mangalam Organics Ltd Q2FY22 consolidated PAT jumps to Rs. 22.31 crore

Mahan Industries Ltd posts loss in Q2FY22

Vardhman Special Steels Ltd Q2FY22 PAT drops QoQ to Rs. 24.29 crore

HDFC Asset Management Company Ltd posts Q2FY22 net profit of Rs. 344.38 crores

Tech Mahindra Ltd board declares special dividend of Rs. 15

TCS Named a Leader in IDC MarketScape for Worldwide Artificial Intelligence IT Services

SunEdison Infrastructure Ltd forms subsidiary

Rama Steel Tubes Limited wins Business Excellence Award of the Year

Maharashtra Scooters Ltd Q2FY22 PAT zooms to Rs. 135.70 crores

Tech Mahindra Ltd consolidated Q2FY22 net profit slips QoQ to Rs. 1338.7 crore

Bigbloc Construction Ltd Q2FY22 consolidated PAT at Rs. 3.14 crore

Kansai Nerolac Paints Ltd reports consolidated PAT of Rs. 92.01 crore, down QoQ, YoY


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020